Illumina, Inc. /
SomaLogic
Illumina expands its proteomics business with SomaLogic acquisition




Source for the buyer and target: Illumina, Inc.
For the buyer and target.
“Illumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology.”
Published 30 Jan 2026
Open the sourceWhat happened
Illumina, Inc. completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. The transaction included Standard BioTools Inc.’s aptamer-based and functional proteomics business. [01]
Illumina paid $350,000,000 in cash, subject to customary adjustments, and the transaction includes potential milestone payments and performance-based royalties. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Illumina expands its proteomics business with SomaLogic acquisition
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly